ABBOTT LABORATORIES for ABBOTT LABORATORIES
Versions of this report
Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.
| Filing | Filed | Amount | Counted |
|---|---|---|---|
| 4th Quarter - Report | Jan 23, 2017 | $790,000 | Replaced |
| 4th Quarter - Amendment (this page) | Oct 19, 2017 | $820,000 | Yes |
What was lobbied
7 issue areas, each in the filer's own words, with who lobbied on it and where.
Trade (domestic/foreign) TRD
Proposals regarding infant nutrition marketing. Issues related to a US Export Certificate. Issues related to WHO Prequalification of medicinal products. Issues related to international price controls on drugs and devices. Asia-Pacific Economic Cooperation Business Advisory Council.
| Lobbyist | Covered position, as disclosed |
|---|---|
| THOMAS EVERS | — |
| JASON GROVE | — |
| ROSEMARY T HAAS | — |
Agriculture AGR
Proposals regarding the 2016 Improving Child Nutrition Integrity and Access Act.
| Lobbyist | Covered position, as disclosed |
|---|---|
| AUSTIN BURNES | — |
| THOMAS EVERS | — |
| ROSEMARY T HAAS | — |
Taxation/Internal Revenue Code TAX
Proposals to reform domestic and international tax structures. Proposals to suspend or repeal the Medical Device Tax.
| Lobbyist | Covered position, as disclosed |
|---|---|
| THOMAS EVERS | — |
| JASON GROVE | — |
| ROSEMARY T HAAS | — |
| ANDREW CORY MOSKOWITZ | — |
Health Issues HCR
S. 1622 FDA Device Accountability Act of 2015. S. 586 National Diabetes Clinical Care Commission Act. H.R. 6 21st Century CURES Act/Senate Innovation Package. H.R. 1192 National Diabetes Clinical Care Commission Act. H.R. 5009 Ensuring Patient Access to Critical Breakthrough Products Act of 2016. Proposals related to Affordable Care Act improvements/repeal and replace. Proposals to modify requirements for diabetes testing supplies. Proposals regarding payments across healthcare sites of service.
| Lobbyist | Covered position, as disclosed |
|---|---|
| AUSTIN BURNES | — |
| THOMAS EVERS | — |
| ROSEMARY T HAAS | — |
| ANDREW CORY MOSKOWITZ | — |
| CYNTHIA B SENSIBAUGH | — |
Medicare/Medicaid MMM
Proposals regarding changes to modernize and update the Clinical Laboratory Fee Schedule. Proposals related to the use of the Unique Device Identification Code. Proposals regarding FDA Framework for Regulatory Oversight of Laboratory Developed Tests (LDTs).
| Lobbyist | Covered position, as disclosed |
|---|---|
| AUSTIN BURNES | — |
| THOMAS EVERS | — |
| ROSEMARY T HAAS | — |
| ANDREW CORY MOSKOWITZ | — |
| CYNTHIA B SENSIBAUGH | — |
Food Industry (safety, labeling, etc.) FOO
Proposals to reduce adult malnutrition and hospital re-admissions.
| Lobbyist | Covered position, as disclosed |
|---|---|
| AUSTIN BURNES | — |
| ANNE DEVLIN | — |
| THOMAS EVERS | — |
| ROSEMARY T HAAS | — |
| CYNTHIA B SENSIBAUGH | — |
Natural Resources NAT
H.R. 5278 Puerto Rico Oversight, Management and Economic Stability Act (PROMESA).
| Lobbyist | Covered position, as disclosed |
|---|---|
| THOMAS EVERS | — |
| ROSEMARY T HAAS | — |
| ANDREW CORY MOSKOWITZ | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.